KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biolife Solutions (BLFS) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Biolife Solutions (BLFS) over the last 14 years, with Q3 2025 value amounting to $47.9 million.

  • Biolife Solutions' Shares Outstanding (Weighted Average) rose 378.92% to $47.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $47.9 million, marking a year-over-year increase of 378.92%. This contributed to the annual value of $46.1 million for FY2024, which is 537.04% up from last year.
  • As of Q3 2025, Biolife Solutions' Shares Outstanding (Weighted Average) stood at $47.9 million, which was up 378.92% from $47.8 million recorded in Q2 2025.
  • Biolife Solutions' 5-year Shares Outstanding (Weighted Average) high stood at $47.9 million for Q3 2025, and its period low was $33.2 million during Q1 2021.
  • For the 5-year period, Biolife Solutions' Shares Outstanding (Weighted Average) averaged around $43.6 million, with its median value being $43.6 million (2023).
  • In the last 5 years, Biolife Solutions' Shares Outstanding (Weighted Average) surged by 5818.91% in 2021 and then surged by 216.3% in 2023.
  • Quarter analysis of 5 years shows Biolife Solutions' Shares Outstanding (Weighted Average) stood at $38.5 million in 2021, then grew by 10.33% to $42.5 million in 2022, then increased by 2.91% to $43.7 million in 2023, then rose by 5.37% to $46.1 million in 2024, then rose by 4.03% to $47.9 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $47.9 million in Q3 2025, compared to $47.8 million in Q2 2025 and $47.1 million in Q1 2025.